131 related articles for article (PubMed ID: 32779819)
1. Effect of simvastatin on cell proliferation and Ras activation in canine tumour cells.
Kobayashi K; Baba K; Kambayashi S; Okuda M
Vet Comp Oncol; 2021 Mar; 19(1):99-108. PubMed ID: 32779819
[TBL] [Abstract][Full Text] [Related]
2. Blockade of isoprenoids biosynthesis by simvastatin induces autophagy-mediated cell death via downstream c-Jun N-terminal kinase activation and cell cycle dysregulation in canine T-cell lymphoma cells.
Kobayashi K; Baba K; Kambayashi S; Okuda M
Res Vet Sci; 2024 Mar; 169():105174. PubMed ID: 38340381
[TBL] [Abstract][Full Text] [Related]
3. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
5. Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells.
Alizadeh J; Zeki AA; Mirzaei N; Tewary S; Rezaei Moghadam A; Glogowska A; Nagakannan P; Eftekharpour E; Wiechec E; Gordon JW; Xu FY; Field JT; Yoneda KY; Kenyon NJ; Hashemi M; Hatch GM; Hombach-Klonisch S; Klonisch T; Ghavami S
Sci Rep; 2017 Mar; 7():44841. PubMed ID: 28344327
[TBL] [Abstract][Full Text] [Related]
6. Statins inhibited the MIP-1α expression via inhibition of Ras/ERK and Ras/Akt pathways in myeloma cells.
Tsubaki M; Mashimo K; Takeda T; Kino T; Fujita A; Itoh T; Imano M; Sakaguchi K; Satou T; Nishida S
Biomed Pharmacother; 2016 Mar; 78():23-29. PubMed ID: 26898421
[TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
Saito A; Saito N; Mol W; Furukawa H; Tsutsumida A; Oyama A; Sekido M; Sasaki S; Yamamoto Y
Melanoma Res; 2008 Apr; 18(2):85-94. PubMed ID: 18337644
[TBL] [Abstract][Full Text] [Related]
9. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells.
Cafforio P; Dammacco F; Gernone A; Silvestris F
Carcinogenesis; 2005 May; 26(5):883-91. PubMed ID: 15705602
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Simvastatin-Induced Inhibition of Tendon Cell Proliferation and Cell Cycle Progression by Geranylgeranyl Pyrophosphate.
Tsai WC; Yu TY; Lin LP; Cheng ML; Chen CL; Pang JH
Toxicol Sci; 2016 Feb; 149(2):326-34. PubMed ID: 26577051
[TBL] [Abstract][Full Text] [Related]
11. Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells.
Blanco-Colio LM; Justo P; Daehn I; Lorz C; Ortiz A; Egido J
Kidney Int; 2003 Jul; 64(1):181-91. PubMed ID: 12787408
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.
Göbel A; Zinna VM; Dell'Endice S; Jaschke N; Kuhlmann JD; Wimberger P; Rachner TD
BMC Cancer; 2020 Jul; 20(1):703. PubMed ID: 32727400
[TBL] [Abstract][Full Text] [Related]
14. The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathways.
Tsubaki M; Fujiwara D; Takeda T; Kino T; Tomonari Y; Itoh T; Imano M; Satou T; Sakaguchi K; Nishida S
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):222-234. PubMed ID: 27805296
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin exerts anticancer effects in osteosarcoma cell lines via geranylgeranylation and c-Jun activation.
Kany S; Woschek M; Kneip N; Sturm R; Kalbitz M; Hanschen M; Relja B
Int J Oncol; 2018 Apr; 52(4):1285-1294. PubMed ID: 29532878
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells.
Torres CG; Olivares A; Stoore C
Oncol Rep; 2015 May; 33(5):2235-44. PubMed ID: 25778435
[TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
Al-Haidari AA; Syk I; Thorlacius H
Biochem Biophys Res Commun; 2014 Mar; 446(1):68-72. PubMed ID: 24582560
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
[TBL] [Abstract][Full Text] [Related]
19. Protein prenylation contributes to the effects of LPS on EFS-induced responses in human isolated bronchi.
Cazzola M; Calzetta L; Page CP; Rinaldi B; Capuano A; Matera MG
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):704-10. PubMed ID: 21278325
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
